Start
Verksamheten
Personal
Nätverk
Kontakt
In English
Publiceringar
» 2010
» Arkiv
IHE Information
IHE Forum
IHEs Nätverk för hälsoekonomer
Kurser i hälsoekonomi
Institutet för Hälso- och
Sjukvårdsekonomi
Box 2127
SE-220 02 Lund
Besök: Råbygatan 2
Tel: 046-32 91 00
info@ihe.se
2010
Beställ publikationer på
publications@ihe.se
Olofsson S, Glenngård A H, Wickström A & Svenningsson A
En skattning av produktionsvinst baserat på en direkt mätning av arbetsförmågan före och efter ett års behandling med Tysabri för personer med Multipel Skleros (MS)
Lund: IHE e-rapport 2010:1
Ghatnekar O, Hjalte F & Taylor M
Cost-effectiveness of dasatinib versus high-dose imatinib in patients with Chronic Myeloid Leukemia (CML), resistant to standard dose imatinib - a Swedish model application
Acta Oncol. 2010 Aug; 49(6): 851-8
Norlin J, Elf J, Svensson PJ & Steen Carlsson K
A Cost-effectiveness Analysis of Diagnostic Algorithms of Deep Vein Thrombosis at the Emergency Department
Thrombosis Research, 2010
Saha S, Gerdtham U-G & Johansson P
Economic Evaluation of Lifestyle Interventions on prevention of diabetes and cardiovascular diseases
International Journal of Environmental Research and Public Health. 2010; 7: 3150-3195
Jarl J, Gerdtham U-G, Ludbrook A & Pietri D
On Measurement of Avoidable and Unavoidable Cost of Alcohol: An Application of Method for Estimating Costs Due To Prior Consumption
International Journal of Environmental Research and Public Health 2010; 7: 2881-2895
Arana A, Allen S, Burkowitz J, Fantoni V, Ghatnekar O, Rico M T, Vanhaverbeke N, Wentworth C E, Brosa M & Arellano F M
Infliximab Paediatric Crohn’s Disease Educational Plan. A European, Cross-Sectional, Multicentre Evaluation
Drug Safety Journal 2010; 33(6): 489-501
Svensson M
Bilaga 7: Utvärdering av Fritt val av hjälpmedel – en enkätundersökning bland hjälpmedelsanvändare i landstingen i Kronoberg, Sörmland och Stockholm
Stockholm: Hjälpmedelsinstitutet, 2010
Svensson M & Edebalk PG
Kundval i äldreomsorgen - Stärks brukarens ställning i ett valfrihetssystem?
Stockholm: Sveriges Kommuner och Landsting, 2010
Erntoft S
The use of health economic evaluations in pharmaceutical priority setting. The case of Sweden
Doktorsavhandling 2010.
Lund: Lund Business Press. Lund Studies in Economic and Management 116.
Erntoft S, Asseburg C, Johnson R, Anell A & Persson U
Vilken betydelse har hälsoekonomi vid prioriteringar? – Ett experiment bland beslutsfattare och en analys av faktiska prioriteringar
Linköping 2010, Prioriteringscentrum 2010:3
Hjalte F, Asseburg C, Tennvall G R
Cost-effectiveness of a barrier-strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden - with model applications for Denmark, Norway and Finland
Journal of the European Academy of Dermatology and Venereology, JEADV, 2010; 24(4): 474-480
Willis M, Svensson M, Löthgren M, Eriksson B, Berntsson A & Persson U
The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden
The European Journal of Health Economics 2010
Persson U, Willis M & Ödegaard K
A case study of ex ante, value-based price and reimbursement decision-making; TLV and rimonabant in Sweden
The European Journal for Health Economics 2010 April; 11(2): 195-203
Hellgren J, Cervin A, Nordling S, Bergman A & Cardell L O
Allergic rhinitis and the common cold – high cost to society
Allergy 2010; 65(6): 776–783
Borg S, Persson U, Jess T, Thompsen O, Ljung T, Riis L & Munkholm P. A
Maximum likelihood estimator of a Markov model for disease activity in Crohn´s disease and ulcerative colitis for annually aggregated partial observations
Medical Decision Making, 2010 Jan-Feb; 30(1): 132-142
Allanson P, Gerdtham U G & Petrie D
Longitudinal analysis of income-related health inequality
Journal of Health Economics 2010; 29(1): 78-86
Steen Carlsson K , Landin-Olsson M, Nyström L, Arnqvist H J, Bolinder J, Östman J & Gudbjörnsdóttir S
Long-term detrimental consequences of the onset of type 1 diabetes on annual earnings-evidence from annual registry data in 1990-2005
Diabetologia 2010; 53(6): 1084-1092
Islam K, Gerdtham U G, Clarke C & Burström K
Does income-related health inequality change as the population ages? Evidence from Swedish panel data
Health Economics 2010; 19(3): 334-349
Jarl J & Gerdtham U G
Wage Penalty of Abstinence and Wage Premium of Drinking - A misclassification bias due to pooling of drinking groups?
Addiction Research and Theory, 2010; 18: 284-297
Ljungvall A & Gerdtham U G
More equal but heavier: a longitudinal analysis of income-related obesity inequality in an adult Swedish cohort
Social Science & Medicine 2010; 70(2): 221-231
Romé Å, Persson U, Ekdahl C & Gard G
Willingness to pay for health improvements of physical activity on prescription
Scandinavian Journal of Public Health, 2010; 38(2): 151-159
Willis M, Persson U, Zoellner Y & Gradl B
Ex Ante, Value-Based Pricing Model for Reimbursement Decision-Making: The Case of Continuous Intraduodenal Infusion of Levodopa/Carbidopa (Duodopa®) in Sweden
Applied Health Economics and Health Policy 2010
Version för utskrift
© IHE 2010
Om webbplatsen
|
Sajtkarta